Niagen Bioscience PE ratio NAGE
Share price divided by earnings per share over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 13.5×
- Peer median
- 15.1×
Niagen Bioscience's PE ratio is 13.5× as of Oct 23, 2026: a share price of $2.43 against $0.18 of earnings per share over the last twelve months.
The median for 4 chemicals stocks of a similar size is 15.1×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 13.5× | 13.5× | 27.2× |
| 2025 | 27.7× | 26.9× | 83.6× |
Against its peers
Companies in Chemicals nearest Niagen Bioscience's size, closest first, today.
| Company | PE ratio |
|---|---|
| NAGENiagen Bioscience | 13.5× |
| FTLFFitlife Brands | 13.5× |
| FTKFlotek Industries | 24.1× |
| BTMDbiote | 10.7× |
| CRONCronos | 16.8× |
| Peer median | 15.1× |
Where Niagen Bioscience ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Niagen Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.